Oncology Articles

Radium-223 from Bench to Bedside – Future Directions for Targeted Alpha Therapy
Joe M O’Sullivan
European Oncology & Haematology. 2018;14(Suppl 2):3–9
DNA Damage Response – An Emerging Target for Groundbreaking Cancer Therapies
Sean Bohen, Mark J O’Connor, Meredith Morgan
European Oncology & Haematology. 2018;14(Suppl 1):2–7
Finding and Treating Gaucher Disease Type 1 – The Role of the Haematologist
Maria-Domenica Cappellini, Elena Cassinerio, Irene Motta, William Morello, Jesús Villarrubia
European Oncology & Haematology. 2018;14(1):50–56 DOI: https://doi.org/10.17925/EOH.2018.14.1.50
Whole-body Vibration Training as a Supportive Therapy During Allogeneic Haematopoietic Stem Cell Transplantation – A Randomised Controlled Trial
Tobias S Kaeding, Marcel Frimmel, Florian Treondlin, Klaus Jung, Wolfram Jung, Gerald Wulf, Lorenz Trümper, Justin Hasenkamp
European Oncology and Haematology. 2018;14(1):33–39 DOI: https://doi.org/10.17925/EOH.2018.14.1.33
New Approaches to Multiple Myeloma
Irene Ghobrial
European Oncology & Haematology. 2018;14(1):18–19 DOI: https://doi.org/10.17925/EOH.2018.14.1.18
Should we Address Biochemical Recurrence of Prostate Cancer as Soon as Possible? Against
Robert Chandler, Antonella Petremolo, Pasquale Rescigno, Johann S De Bono
European Oncology & Haematology. 2018;14(1):14–15 DOI: https://doi.org/10.17925/EOH.2018.14.1.14
Should we Address Biochemical Recurrence of Prostate Cancer as Soon as Possible? In Favour
Hendrik Van Poppel
European Oncology & Haematology, 2018;14(1):12–13 DOI: https://doi.org/10.17925/EOH.2018.14.1.12
Bilateral Obliterative External Otitis in the Context of Chronic Iron Deficiency—Report of Two Cases
Michel Kmeid, Jade Nehme
Oncology & Hematology Review. 2018;14(1):42–44 DOI: https://doi.org/10.17925/OHR.2018.14.1.42
Pediatric Anaplastic Large Cell Lymphoma— A Review
Soumitra Tole, Laura Wheaton, Sarah Alexander
Oncology & Hematology Review. 2018;14(1):21–27 DOI: https://doi.org/10.17925/OHR.2018.14.1.21
Concepts of Precision Medicine in Breast Cancer
Eleni Andreopoulou
Oncology & Hematology Review. 2018;14(1):16–17 DOI: https://doi.org/10.17925/OHR.2018.14.1.16
Early Intervention in Multiple Myeloma—Exploring New Frontiers
Shaji K Kumar
Oncology & Hematology Review. 2018;14(1):12–13 DOI: https://doi.org/10.17925/OHR.2018.14.1.12
Changing Paradigms in the Treatment of Renal Cancer
Ulka Vaishampayan
Oncology & Hematology Review. 2018;14(1):20 DOI: https://doi.org/10.17925/OHR.2018.14.1.20
New Advances in the Treatment of Non-Small Cell Lung Cancer
Suresh S Ramalingam
Oncology & Hematology Review. 2018;14(1):18–19 DOI: https://doi.org/10.17925/OHR.2018.14.1.18
Detecting an ALK Rearrangement via Liquid Biopsy Enabled a Targeted Therapy-based Approach for Treating a Patient with Advanced Non-small Cell Lung Cancer
Alejandro R Calvo, Gabriel H Ibarra, Cecile Rose T Vibat, Veena M Singh
Oncology & Hematology Review. 2018;14(1):38–41 DOI: https://doi.org/10.17925/OHR.2018.14.1.38
Advances in Cancer Research and Translational Medicine
Elaine R Mardis
Oncology & Hematology Review. 2018;14(1):14–15 DOI: https://doi.org/10.17925/OHR.2018.14.1.14
Radiopharmaceuticals for the Detection of Recurrent Prostate Cancer
Bertrand Tombal
European Oncology & Haematology. 2018;14(1):16–17 DOI: https://doi.org/10.17925/EOH.2018.14.1.16
The Belarus Experience of Pelvic Artery Embolisation in Patients with Advanced and Recurrent Cervical Cancer Presenting with Haemorrhage
Olga P Matylevich, Vladimir V Akinfeev, Thomas C Randall, Kathleen M Schmeler, Oleg G Sukonko
European Oncology & Haematology, 2018;14(1):45–49 DOI: https://doi.org/10.17925/EOH.2018.14.1.45
Rolapitant in the Current Management of Chemotherapy-induced Nausea and Vomiting
Bernardo L Rapoport, Pere Gascon, Florian Scotte, Karin Jordan, Massimo Di Maio, Sussanne Borjeson, Sam H Ahmedzai
European Oncology & Haematology, 2018;14(1):[Online only]
More than a Gel – Hyaluronic Acid, a Central Component in the Microenvironment of Pancreatic Cancer
Thomas Seufferlein, Michel Ducreux, Manuel Hidalgo, Gerald Prager, Eric Van Cutsem
European Oncology & Haematology. 2018;14(1):40–44 DOI: https://doi.org/10.17925/EOH.2018.14.1.40
The Impact of Biosimilars in Supportive Care in Cancer
Paul Cornes, Matti S Aapro
European Oncology & Haematology. 2018;14(1):20–32 DOI: https://doi.org/10.17925/EOH.2018.14.1.20